{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T10:13:23Z","timestamp":1695118403826},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:p>A case of a 19-year-old female with low-risk acute myeloid leukemia is presented who was diagnosed with idiopathic hyperammonemic encephalopathy following the development of abrupt neurologic decline, respiratory alkalosis, and elevated plasma ammonia levels of unknown etiology. Delayed symptom recognition of this exceedingly rare condition contributes to the often fatal outcomes of idiopathic hyperammonemic encephalopathy. As illustrated by this case, prompt diagnosis and utilization of a variety of ammonia-modulating treatment modalities can result in remarkable clinical recovery. This case provides guidance to clinicians in counseling families about the possibility of neurologic recovery in similar clinical scenarios.<\/jats:p>","DOI":"10.1097\/mph.0000000000001579","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T11:29:09Z","timestamp":1565782149000},"page":"e452-e455","source":"Crossref","is-referenced-by-count":1,"title":["Survival and Neurologic Recovery After Prompt Diagnosis and Aggressive Management of Severe Idiopathic Hyperammonemic Encephalopathy in a Patient with Acute Myeloid Leukemia"],"prefix":"10.1097","volume":"42","author":[{"given":"Ross","family":"Mangum","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Texas Children\u2019s Cancer and Hematology Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Soler-Alfonso","sequence":"additional","affiliation":[{"name":"Department of Molecular and Human Genetics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherri","family":"Birchansky","sequence":"additional","affiliation":[{"name":"Department of Radiology, Baylor College of Medicine"},{"name":"Department of Pediatric Radiology, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Texas Children\u2019s Cancer and Hematology Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1200\/JCO.2014.55.3628","article-title":"Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children\u2019s Oncology Group trial AAML0531","volume":"32","author":"Gamis","year":"2014","journal-title":"J Clin Oncol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MPH.0000000000001062","article-title":"Symptomatic hyperammonemia with Erwinia chrysanthemi-derived asparaginase in pediatric leukemia patients","volume":"40","author":"Gossai","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1080\/10428190701509822","article-title":"Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy","volume":"48","author":"Nott","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2014.06.003","article-title":"Pathophysiology of brain dysfunction in hyperammonemic syndromes: the many faces of glutamine","volume":"113","author":"Butterworth","year":"2014","journal-title":"Mol Genet Metab"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/MPH.0b013e3181b8beb1","article-title":"Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia","volume":"31","author":"Jaing","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0197-0186(02)00032-3","article-title":"Direct and indirect enhancement of GABAergic neurotransmission by ammonia: implications for the pathogenesis of hyperammonemic syndromes","volume":"41","author":"Basile","year":"2002","journal-title":"Neurochem Int"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11011-008-9113-6","article-title":"Signaling factors in the mechanism of ammonia neurotoxicity","volume":"24","author":"Norenberg","year":"2009","journal-title":"Metab Brain Dis"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1011666612822","article-title":"Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia","volume":"16","author":"Rao","year":"2001","journal-title":"Metab Brain Dis"},{"key":"R10-20230918","first-page":"1184","article-title":"Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders","volume":"24","author":"Takanashi","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00005792-200205000-00007","article-title":"Hyperammonemic encephalopathy","volume":"81","author":"Brusilow","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0022-5347(17)50606-0","article-title":"Ammoniagenic coma following ureterosigmoidostomy","volume":"131","author":"Kaufman","year":"1984","journal-title":"J Urol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"284re3","DOI":"10.1126\/scitranslmed.aaa8419","article-title":"Disseminated ureaplasma infection as a cause of fatal hyperammonemia in humans","volume":"7","author":"Bharat","year":"2015","journal-title":"Sci Transl Med"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0002-9343(88)80239-0","article-title":"Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases","volume":"85","author":"Mitchell","year":"1988","journal-title":"Am J Med"},{"key":"R16-20230918","first-page":"1119","article-title":"Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation","volume":"17","author":"Davies","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/clpt.2012.112","article-title":"Ammonia-lowering strategies for the treatment of hepatic encephalopathy","volume":"92","author":"Rose","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.leukres.2009.01.008","article-title":"Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: case report and review of the literature","volume":"33","author":"Metzeler","year":"2009","journal-title":"Leuk Res"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"8512721","DOI":"10.1155\/2016\/8512721","article-title":"Hyperammonemia: what urea-lly need to know: case report of severe noncirrhotic hyperammonemic encephalopathy and review of the literature","volume":"2016","author":"Upadhyay","year":"2016","journal-title":"Case Rep Med"},{"key":"R20-20230918","first-page":"105","article-title":"Treatment of hyperammonemia in liver failure","volume":"17","author":"Jover-Cobos","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:17:28Z","timestamp":1695014248000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001579","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,12]]}}}